clinical trial · NCT05800743
Evaluation of the GORE® Ascending Stent Graft
W.L.Gore & Associates·N/A·enrolling by invitation·n = 370
Aortic Aneurysm, ThoracicPseudoaneurysmAortic DissectionAorta; LesionGORE® Ascending Stent Graft (ASG device)GORE® Thoracic Aortic Graft Thoracic Branch Endoprosthesis (TBE Device)Surgery
brief summary
The primary objective of ARISE II is to assess the safety and effectiveness of the GORE® Ascending Stent Graft device in the treatment of lesions involving the ascending aorta and aortic arch.
started
Nov 28, 2023
primary completion
Oct 1, 2029
completion
Jan 1, 2034
last updated
Sep 10, 2025
official title
Evaluation of the GORE® Ascending Stent Graft in the Treatment of Lesions of the Ascending Aorta
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol